BHVN Q3 2019 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena

BHVNBiohaven Ltd.

$1B

Q3 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$90M

Net Income

-$106M

EPS (Diluted)

$-2.04

QoQ Revenue Growth

NaN%

Balance Sheet

Total Assets

$439M

Total Liabilities

$320M

Stockholders' Equity

$119M

Cash & Equivalents

$417M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$90M	-$55M	-64.7%
Net Income	-$106M	-$61M	-72.8%